Author:
Holdhoff Matthias,Kreuzer Karl-Anton,Appelt Christine,Scholz Regina,Na Il-Kang,Hildebrandt Bert,Riess Hanno,Jordan Andreas,Schmidt Christian A.,Van Etten Richard A.,Dörken Bernd,le Coutre Philipp
Subject
Cell Biology,Hematology,Molecular Biology,Molecular Medicine
Reference20 articles.
1. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative;Buchdunger;Cancer Res.,1996
2. Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-Kit and platelet-derived growth factor receptors;Buchdunger;J. Pharmacol. Exp. Ther.,2000
3. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia;Kantarjian;N. Engl. J. Med.,2002
4. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta;Apperley;N. Engl. J. Med.,2002
5. Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders;Pardanani;Blood,2003
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献